{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:27:58Z","timestamp":1790209678156,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41385-019-0131-y","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T12:06:01Z","timestamp":1548158761000},"page":"827-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection"],"prefix":"10.1016","volume":"12","author":[{"given":"Derek J.","family":"Royer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua F.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea M.","family":"Larabee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaina M.","family":"Reagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie H.","family":"Sjoelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1038\/s41385-019-0131-y_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.it.2017.11.007","article-title":"When Clarity Is Crucial: Regulating Ocular Surface Immunity","volume":"39","author":"Foulsham","year":"2018","journal-title":"Trends in Immunology"},{"key":"10.1038\/s41385-019-0131-y_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/imm.12716","article-title":"Mucosal immune tolerance at the ocular surface in health and disease","volume":"150","author":"Galletti","year":"2017","journal-title":"Immunology"},{"issue":"6","key":"10.1038\/s41385-019-0131-y_bib3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/JLB.3MIR0817-337R","article-title":"Negative regulators that mediate ocular immune privilege","volume":"103","author":"Taylor","year":"2018","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1038\/s41385-019-0131-y_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/157339511796196593","article-title":"Cornea: window to ocular immunology","author":"Niederkorn","year":"2011","journal-title":"Curr. Immunol. Rev."},{"key":"10.1038\/s41385-019-0131-y_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.exer.2014.02.007","article-title":"Wounding the cornea to learn how it heals","volume":"121","author":"Stepp","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1038\/s41385-019-0131-y_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jtos.2016.11.003","article-title":"Visual acuity and quality of life in dry eye disease: Proceedings of the OCEAN group meeting","volume":"15","author":"Ben\u00edtez-Del-Castillo","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1038\/s41385-019-0131-y_bib7","doi-asserted-by":"crossref","unstructured":"Henry, C., Palioura, S., Amescua, G. & Alfonso, E. Role of steroids in the treatment of bacterial keratitis. Clin. Ophthalmol. (2016). https:\/\/doi.org\/10.2147\/OPTH.S80411.","DOI":"10.2147\/OPTH.S80411"},{"issue":"9-10","key":"10.1038\/s41385-019-0131-y_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.micinf.2017.12.014","article-title":"Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy","volume":"20","author":"Rajasagi","year":"2018","journal-title":"Microbes and Infection"},{"key":"10.1038\/s41385-019-0131-y_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1038\/s41385-019-0131-y_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41385-019-0131-y_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17469899.2015.1004315","article-title":"The current state of vaccine development for ocular HSV-1 infection","volume":"10","author":"Royer","year":"2015","journal-title":"Expert. Rev. Ophthalmol."},{"key":"10.1038\/s41385-019-0131-y_bib12","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1128\/JVI.72.7.5343-5350.1998","article-title":"The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation","volume":"72","author":"Sawtell","year":"1998","journal-title":"J. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib13","doi-asserted-by":"crossref","first-page":"e1004237","DOI":"10.1371\/journal.ppat.1004237","article-title":"Lytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional response","volume":"10","author":"Ma","year":"2014","journal-title":"PLoS. Pathog."},{"key":"10.1038\/s41385-019-0131-y_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/599329","article-title":"Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues","volume":"200","author":"Remeijer","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1038\/s41385-019-0131-y_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1167\/iovs.15-18365","article-title":"Extended release of an anti\u2013heparan sulfate peptide from a contact lens suppresses corneal herpes simplex virus-1 infection","volume":"57","author":"Jaishankar","year":"2016","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1038\/s41385-019-0131-y_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/cpt.647","article-title":"Drugs in development for herpes simplex and varicella zoster virus","volume":"102","author":"Birkmann","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"428","key":"10.1038\/s41385-019-0131-y_bib17","doi-asserted-by":"crossref","first-page":"eaan5861","DOI":"10.1126\/scitranslmed.aan5861","article-title":"An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye","volume":"10","author":"Jaishankar","year":"2018","journal-title":"Science Translational Medicine"},{"key":"10.1038\/s41385-019-0131-y_bib18","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1128\/JVI.00788-15","volume":"89","author":"Khan","year":"2015","journal-title":"J. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib19","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2015.12.076","article-title":"Status of vaccine research and development of vaccines for herpes simplex virus","volume":"34","author":"Johnston","year":"2016","journal-title":"Vaccine"},{"key":"10.1038\/s41385-019-0131-y_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.1700145","article-title":"Bolstering the number and function of HSV-1-specific CD8 + effector memory T cells and tissue-resident memory T cells in latently infected trigeminal ganglia reduces recurrent ocular herpes infection and disease","volume":"199","author":"Khan","year":"2017","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib21","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1128\/JVI.00517-16","article-title":"A highly efficacious herpes simplex virus 1 vaccine blocks viral pathogenesis and prevents corneal immunopathology via humoral immunity","volume":"90","author":"Royer","year":"2016","journal-title":"J. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib22","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.4049\/jimmunol.1700316","article-title":"The neonatal Fc receptor and complement fixation facilitate prophylactic vaccine-mediated humoral protection against viral infection in the ocular mucosa","volume":"199","author":"Royer","year":"2017","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib23","doi-asserted-by":"crossref","first-page":"e02316","DOI":"10.1128\/JVI.02342-16","article-title":"Impact of type 1 interferon on the safety and immunogenicity of an experimental live-attenuated herpes simplex virus type 1 vaccine in mice","volume":"91","author":"Royer","year":"2017","journal-title":"J. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib24","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1099\/vir.0.2008\/005066-0","article-title":"A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones","volume":"89","author":"Proenca","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib25","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1167\/iovs.15-16900","article-title":"Granulocytes in ocular HSV-1 infection: opposing roles of mast cells and neutrophils","volume":"56","author":"Royer","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1038\/s41385-019-0131-y_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep46116","article-title":"Second harmonic generation imaging of corneal stroma after infection by Pseudomonas aeruginosa","volume":"7","author":"Robertson","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1038\/s41385-019-0131-y_bib27","first-page":"332","article-title":"Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL\/6 mice","volume":"22","author":"Larabee","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1038\/s41385-019-0131-y_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1038\/s41385-019-0131-y_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/infdis\/jiu177","article-title":"Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine","volume":"210","author":"Awasthi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1038\/s41385-019-0131-y_bib30","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4049\/jimmunol.175.2.1100","article-title":"Critical role for the oligoadenylate synthetase\/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection","volume":"175","author":"Austin","year":"2005","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib31","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4049\/jimmunol.0803878","article-title":"Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice","volume":"182","author":"Conrady","year":"2009","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib32","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/mi.2015.124","article-title":"A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin","volume":"9","author":"Royer","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.virol.2016.06.016","article-title":"Neuronal IFN signaling is dispensable for the establishment of HSV-1 latency","volume":"497","author":"Rosato","year":"2016","journal-title":"Virology"},{"key":"10.1038\/s41385-019-0131-y_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/jvi.63.2.759-768.1989","article-title":"Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency","volume":"63","author":"Leib","year":"1989","journal-title":"J. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1574-6976.2011.00320.x","article-title":"The molecular basis of herpes simplex virus latency","volume":"36","author":"Nicoll","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1038\/s41385-019-0131-y_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni.2548","article-title":"Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21","volume":"14","author":"McEwan","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature"},{"key":"10.1038\/s41385-019-0131-y_bib38","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1167\/iovs.15-17074","article-title":"A herpes simplex virus type 1 human asymptomatic CD8 + T-cell epitopes-based vaccine protects against ocular herpes in a \u201chumanized\u201d HLA transgenic rabbit model","volume":"56","author":"Srivastava","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1038\/s41385-019-0131-y_bib39","doi-asserted-by":"crossref","unstructured":"Khan, A. A. et al. Human asymptomatic epitope peptide\/CXCL10-based prime\/pull vaccine induces herpes simplex virus-specific gamma interferon-positive CD107 + CD8 + T cells that infiltrate the corneas and trigeminal ganglia of humanized HLA transgenic rabbits and protect against ocular herpes challenge. J. Virol. 92, e00535\u201318 (2018).","DOI":"10.1128\/JVI.00535-18"},{"key":"10.1038\/s41385-019-0131-y_bib40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1164164","article-title":"Noncytotoxic lytic granule-mediated CD8 + T cell inhibition of HSV-1 reactivation from neuronal latency","volume":"322","author":"Knickelbein","year":"2008","journal-title":"Science"},{"key":"10.1038\/s41385-019-0131-y_bib41","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.4049\/jimmunol.1003735","article-title":"Defining the herpes simplex virus-specific CD8 + T cell repertoire in C57BL\/6 mice","volume":"186","author":"St Leger","year":"2011","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib42","first-page":"938","article-title":"Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis","volume":"25","author":"Russell","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1038\/s41385-019-0131-y_bib43","first-page":"1929","article-title":"Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology","volume":"31","author":"Hendricks","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1038\/s41385-019-0131-y_bib44","doi-asserted-by":"crossref","first-page":"10930","DOI":"10.1128\/JVI.74.23.10930-10938.2000","article-title":"Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans","volume":"74","author":"Koelle","year":"2000","journal-title":"J. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib45","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.4049\/jimmunol.1600574","article-title":"Herpesvirus-associated lymphadenitis distorts fibroblastic reticular cell microarchitecture and attenuates CD8 T cell responses to neurotropic infection in mice lacking the STING-IFN\u03b1\/\u03b2 defense pathways","volume":"197","author":"Royer","year":"2016","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1586\/14760584.2014.910121","article-title":"Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?","volume":"13","author":"Halford","year":"2014","journal-title":"Expert. Rev. Vaccin."},{"key":"10.1038\/s41385-019-0131-y_bib48","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1074\/mcp.M116.058552","article-title":"HVint: a strategy for identifying novel protein-protein interactions in herpes simplex virus type 1","volume":"15","author":"Ashford","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"10.1038\/s41385-019-0131-y_bib49","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.ophtha.2010.07.010","article-title":"Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis","volume":"117","author":"Hamrah","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1038\/s41385-019-0131-y_bib50","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4049\/jimmunol.1700520","article-title":"The plasticity and stability of regulatory T cells during viral-induced inflammatory lesions","volume":"199","author":"Bhela","year":"2017","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib51","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ni0904-878","article-title":"To help and help not","volume":"5","author":"Homann","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib52","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ni1102","article-title":"Deliberate removal of T cell help improves virus-neutralizing antibody production","volume":"5","author":"Recher","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib53","doi-asserted-by":"crossref","first-page":"e1005729","DOI":"10.1371\/journal.ppat.1005729","article-title":"Lytic promoters express protein during herpes simplex virus latency","volume":"12","author":"Russell","year":"2016","journal-title":"PLoS. Pathog."},{"key":"10.1038\/s41385-019-0131-y_bib54","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4049\/jimmunol.1600207","article-title":"Resident T cells are unable to control herpes simplex virus-1 activity in the brain ependymal region during latency","volume":"197","author":"Menendez","year":"2016","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","article-title":"Corneal nerves in health and disease","volume":"59","author":"Shaheen","year":"2014","journal-title":"Surv. Ophthalmol."},{"key":"10.1038\/s41385-019-0131-y_bib56","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/JVI.01166-13","article-title":"Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells","volume":"88","author":"Duan","year":"2014","journal-title":"J. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12985-016-0634-z","article-title":"Human cytomegalovirus reactivation from latency: validation of a \u201cswitch\u201d model in vitro","volume":"13","author":"Arcangeletti","year":"2016","journal-title":"Virol. J."},{"key":"10.1038\/s41385-019-0131-y_bib58","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/INF.0b013e3181acf84f","article-title":"Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008","volume":"28","author":"Tseng","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1038\/s41385-019-0131-y_bib59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing incidence of herpes zoster over a 60-year period from a population-based study","volume":"63","author":"Kawai","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1038\/s41385-019-0131-y_bib60","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib61","doi-asserted-by":"crossref","first-page":"8349","DOI":"10.1128\/JVI.00924-14","article-title":"CD4 + T-cell help enhances NK cell function following therapeutic HIV-1 vaccination","volume":"88","author":"Jost","year":"2014","journal-title":"J. Virol."},{"key":"10.1038\/s41385-019-0131-y_bib62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nri.2015.9","article-title":"Natural killer cell memory in infection, inflammation and cancer","volume":"16","author":"Cerwenka","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib63","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20090303","article-title":"T follicular helper cells differentiate from Th2 cells in response to helminth antigens","volume":"206","author":"Zaretsky","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1038\/s41385-019-0131-y_bib64","doi-asserted-by":"crossref","first-page":"e1005945","DOI":"10.1371\/journal.ppat.1005945","article-title":"Type I interferons induce T regulatory 1 responses and restrict humoral immunity during experimental malaria","volume":"12","author":"Zander","year":"2016","journal-title":"PLoS. Pathog."},{"key":"10.1038\/s41385-019-0131-y_bib65","first-page":"149135","article-title":"Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections","volume":"2012","author":"Chentoufi","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/mi.2017.26","article-title":"Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection","volume":"11","author":"Gurung","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib67","doi-asserted-by":"crossref","first-page":"e06054","DOI":"10.7554\/eLife.06054","article-title":"Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease","volume":"4","author":"Petro","year":"2015","journal-title":"eLife"},{"key":"10.1038\/s41385-019-0131-y_bib68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4049\/jimmunol.65.1.135","article-title":"Studies of the protective effect of gamma globulin against herpes simplex infections in mice","volume":"65","author":"Cheever","year":"1950","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib69","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/261505a0","article-title":"Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice","volume":"261","author":"Baron","year":"1976","journal-title":"Nature"},{"key":"10.1038\/s41385-019-0131-y_bib70","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/infdis\/140.4.534","article-title":"Ocular","volume":"140","author":"Davis","year":"1979","journal-title":"J. Infect. Dis."},{"key":"10.1038\/s41385-019-0131-y_bib71","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/iai.34.1.192-199.1981","article-title":"Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease","volume":"34","author":"Dix","year":"1981","journal-title":"Infect. Immun."},{"key":"10.1038\/s41385-019-0131-y_bib72","doi-asserted-by":"crossref","unstructured":"Jiang, Y. et al. Maternal antiviral immunoglobulin accumulates in neural tissue of neonates to prevent HSV neurological disease. mBio. 8, e00678\u201317 (2017).","DOI":"10.1128\/mBio.00678-17"},{"key":"10.1038\/s41385-019-0131-y_bib73","doi-asserted-by":"crossref","first-page":"e0116091","DOI":"10.1371\/journal.pone.0116091","article-title":"Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine","volume":"10","author":"Geltz","year":"2015","journal-title":"PLoS. One."},{"key":"10.1038\/s41385-019-0131-y_bib74","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/jit651","article-title":"Correlate of immune protection against HSV-1 genital disease in vaccinated women","volume":"209","author":"Belshe","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1038\/s41385-019-0131-y_bib75","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.137.5.1636","article-title":"Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade","volume":"137","author":"Fries","year":"1986","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-019-0131-y_bib76","doi-asserted-by":"crossref","first-page":"e1006741","DOI":"10.1371\/journal.ppat.1006741","article-title":"The pUL37 tegument protein guides alpha-herpesvirus retrograde axonal transport to promote neuroinvasion","volume":"13","author":"Richards","year":"2017","journal-title":"PLoS. Pathog."},{"issue":"8","key":"10.1038\/s41385-019-0131-y_bib77","doi-asserted-by":"crossref","first-page":"e02117","DOI":"10.1128\/JVI.02156-17","article-title":"Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses against Herpesvirus Infection and Disease","volume":"92","author":"Lopes","year":"2018","journal-title":"Journal of Virology"},{"key":"10.1038\/s41385-019-0131-y_bib78","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"Moyer","year":"2016","journal-title":"J. Clin. Invest."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41385-019-0131-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41385-019-0131-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922004263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922004263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41385-019-0131-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:14:01Z","timestamp":1761830041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922004263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1933021922004263"],"URL":"https:\/\/doi.org\/10.1038\/s41385-019-0131-y","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41385-019-0131-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}